[1]
Osman Özdoğan et al. 2020. The impact of direct-acting antiviral treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients: temporary? permanent?. Turkish Journal of Gastroenterology. 31, 5 (Apr. 2020), 384–392.